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ABSTRACT
Nucleotides function in a variety of biological reac-
tions; however, they can undergo various chemical
modifications. Such modified nucleotides may be
toxic to cells if not eliminated from the nucleotide
pools. We performed a screen for modified-
nucleotide binding proteins and identified human
nucleoside diphosphate linked moiety X-type motif
16 (NUDT16) protein as an inosine triphosphate
(ITP)/xanthosine triphosphate (XTP)/GTP-binding
protein. Recombinant NUDT16 hydrolyzes purine
nucleoside diphosphates to the corresponding nu-
cleoside monophosphates. Among 29nucleotides
examined, the highest kcat/Km values were for
inosine diphosphate (IDP) and deoxyinosine diphos-
phate (dIDP). Moreover, NUDT16 moderately hydro-
lyzes (deoxy)inosine triphosphate ([d]ITP). NUDT16
is mostly localized in the nucleus, and especially in
the nucleolus. Knockdown of NUDT16 in HeLa MR
cells caused cell cycle arrest in S-phase, reduced
cell proliferation, increased accumulation of
single-strand breaks in nuclear DNA as well as
increased levels of inosine in RNA. We thus
concluded that NUDT16 is a (deoxy)inosine
diphosphatase that may function mainly in the
nucleus to protect cells from deleterious effects
of (d)ITP.
INTRODUCTION
Intracellular free nucleotides play essential roles as precur-
sors in the synthesis of DNA and RNA, and as molecules
for energy storage, cofactors of metabolic pathways and
regulators of signal transduction. Free nucleotides can,
however, undergo various chemical modiﬁcations by
endogenous and exogenous reactive molecules, some of
which are inevitably produced in living cells. Chemical
modiﬁcations may alter the properties of nucleotides,
including their interaction with other molecules (1).
Some modiﬁed deoxynucleotides are known to be
incorporated into and to accumulate in newly synthesized
DNA during DNA replication. Modiﬁed nucleotides,
accumulated in either the nucleotide pool or DNA, may
inhibit DNA or RNA polymerases during replication
or transcription, reduce polymerase ﬁdelity or alter the
DNA structure, thus resulting in mutagenesis and carcino-
genesis (2,3), cell death and degenerative disorders (4,5)
or senescence and aging (6). In addition to DNA metab-
olism, the other biological functions of canonical nucleo-
tides may also be adversely aﬀected by modiﬁed
nucleotides. Therefore, because modiﬁed nucleotides are
constantly generated under physiological conditions, it is
crucially important to understand how they are eliminated
from cells.
It had been established that cells are equipped with
speciﬁc enzymes to hydrolyze modiﬁed nucleoside triphos-
phates to the corresponding monophosphates to
avoid their deleterious eﬀects (4,7). Deoxyuridine
triphosphatase (dUTPase), for example, hydrolyzes
dUTP, thus preventing its incorporation into DNA. We
have previously demonstrated that MTH1 hydrolyzes
oxidized purine nucleoside triphosphates, such as
8-oxo-20-deoxyguanosine triphosphate (8-oxo-dGTP) or
8-oxoGTP and prevents their incorporation into DNA
or RNA (4).
Deamination of purine bases is one of the major
chemical modiﬁcations that occurs to nucleotides under
physiological conditions (8). Deamination of adenine
at C6 or guanine at C2 generates hypoxanthine or
xanthine, respectively, suggesting that (deoxy)inosine tri-
phosphate ([d]ITP) and (deoxy)xanthosine triphosphate
([d]XTP) can be generated from (d)ATP and (d)GTP,
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normal intermediate of de novo synthesis of purine nucleo-
tides (9), and most cells can generate IDP or ITP from
IMP (10). If IDP is converted to dIDP by ribonucleotide
reductase, increased dITP levels will result (11).
Incorporation of such deaminated purine nucleotides
into DNA or RNA causes genomic mutations or synthesis
of abnormal proteins because hypoxanthine and xanthine
can mis-pair with cytosine or thymine (12,13).
In human and rodents, ITPA, an inosine triphosphatase
(ITPase), has been reported to hydrolyze (d)ITP and XTP
to the corresponding nucleoside monophosphates and
pyrophosphates (14,15). We have previously reported
that Itpa knockout (KO) mice die before weaning with
features of growth retardation and heart failure. In
addition, these mice show accumulation of IMP in
cellular RNA in various tissues or accumulation of ITP
in the nucleotide pool of erythrocytes (16). The heart
failure in Itpa-KO mice suggests that an accumulation of
ITP in the nucleotide pool might impair some functions of
adenosine triphosphate (ATP), such as ATP-dependent
actomyosin contraction (17). In humans, some variants
of ITPA are reported to be associated with decreased
ITPase activity (18,19). In erythrocytes of ITPA-deﬁcient
individuals, it was established that the level of ITP, which
is not detected in normal individuals, is increased to a
detectable level, as observed in Itpa-KO mice. ITPA deﬁ-
ciency in patients with inﬂammatory bowel disease is,
however, likely to be related to azathioprine intolerance,
but does not cause any severe phenotype (19,20). To date,
it is not known why ITPA deﬁciency causes a severe
phenotype in mouse but not in humans. We, therefore,
hypothesized that human cells are equipped with a com-
pensatory mechanism which can eﬃciently suppress the
ITPA deﬁciency.
In the present study, to identify novel ITP hydrolyzing
enzymes or proteins that target ITP, we performed a com-
prehensive screen of proteins that speciﬁcally bind to ITP
immobilized on Sepharose beads. We identiﬁed human
nucleoside diphosphate linked moiety X-type motif 16
(NUDT16) protein (Swiss-Prot accession no., Q96DE0.2).
MATERIALS AND METHODS
Puriﬁcation and identiﬁcation of modiﬁed
nucleotide-binding proteins
Modiﬁed nucleotide-binding proteins were puriﬁed and
identiﬁed with pull-down assays as follows. g-amino-
octyl-nucleoside 50-triphosphate-Sepharose (phosphate-
NTP Sepharose) and/or 20/30-O-(2-aminoethyl-
carbamoyl)-nucleoside 50-triphosphate-Sepharose (ribose-
NTP Sepharose) for GTP, ATP, XTP, ITP, 8-oxo-GTP
and 2-OH-ATP were purchased from Jena Bioscience
(Jena, Germany) and used for pull-down assays. The cell
extract of SH-SY5Y cells was prepared by sonication of
cells in lysis buﬀer [1ml for 5   10
7 cells, 25mM Tris–HCl
pH 7.5, 100mM NaCl, 10mM MgCl2, 0.05% Nonidet
P-40 (NP-40), 1mM dithiothreitol (DTT), 1% protease
inhibitor cocktail (Nacalai Tesque, Kyoto, Japan)] and
clariﬁed by centrifugation, as described previously (21).
Protein concentration in the supernatant was measured
with a DC-protein assay kit (Bio-Rad, Hercules, CA,
USA) using bovine serum albumin (BSA) as a standard.
Twenty microliters of each phosphate-NTP Sepharose,
ribose-NTP Sepharose, and Sepharose carrier matrix
were individually suspended in 1ml of the supernatant,
incubated for 15min at 4 C, and washed three times
with the lysis buﬀer without protease inhibitor cocktail.
Bound proteins in each pulled-down sample were eluted
with 40mlo f2 SDS sampling buﬀer (Sigma-Aldrich, St
Louis, MO, USA), separated by SDS-PAGE, stained by
silver staining with EzStain Silver kit (ATTO Co., Tokyo,
Japan), and analyzed by LC-MS/MS, as described
previously (21). Collision-induced dissociation spectra
were acquired and compared with those in the
International Protein Index (IPI version 3.26; European
Bioinformatics Institute, Hinxton, UK) using the
MASCOT search engine (Matrix Science, Boston, MA,
USA). The high-scoring peptide sequences (MASCOT
score >45) assigned by MASCOT were manually con-
ﬁrmed by comparison with the corresponding collision-
induced dissociation spectra. Finally, we selected as can-
didate proteins those proteins for which multiple peptides
were identiﬁed in this analysis.
Nucleotide-hydrolyzing assay with His-NUDT16
Each substrate nucleotide was incubated in reaction buﬀer
(25mM Tris–HCl pH 7.5, 150mM KCl, 5mM MgCl2,
0.01% NP-40, 100mg/ml BSA, 1mM DTT) for 10min at
37 C. Then, an equal volume of reaction buﬀer containing
100mM recombinant NUDT16 with a His-tag at the N
terminus (His-NUDT16), was mixed with the substrate
solution. The mixture was further incubated at 37 C for
0–60min, and then mixed with ice-cold EDTA to a ﬁnal
concentration of 50mM to stop the reaction. The reaction
products were clariﬁed by centrifugation at 9000g for
5min at 4 C, and then separated on a Wakopak Handy
ODS column (Wako, Osaka, Japan) or on a TSK gel
DEAE-2SW column (Tohso, Tokyo, Japan) using an
HPLC system, at a ﬂow rate of 0.6ml/min with HPLC
buﬀer 1 (0.1M potassium phosphate buﬀer pH 4.0) or
at 0.8ml/min with HPLC buﬀer 2 (75mM sodium phos-
phate buﬀer pH 6.4, 5% acetonitrile, 0.4mM EDTA).
Nucleotides were quantiﬁed by ultraviolet (UV) absorp-
tion. Kinetic parameters, kcat and Km, were calculated by a
ﬁt of the velocity data to the Michaelis Menten equation
using the SigmaPlot analysis software version 11 with
Enzyme Kinetics Module 1.3 (Systat Software, San Jose,
CA, USA).
Free phosphates were quantiﬁed colorimetrically with a
modiﬁed Malachite Green phosphate detection method
using Biomol Green reagent (Enzo Life Sciences
International, Plymouth Meeting, PA, USA) (22,23).
One-hundred microliters of the Biomol Green reagent
was added to 50ml of each reaction mixture, and the
mixture was incubated for 30min at room temperature.
The change in absorbance at 620nm was measured and
used to determine free phosphate concentrations by com-
parison with a standard curve.
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All siRNA oligonucleotides used in this study, NUDT16
siRNA#1 (Silencer Select NUDT16 siRNA; #s43642),
NUDT16 siRNA#2 (Silencer NUDT16 siRNA; #:
38731), control siRNA#1 (Silencer Select Negative
Control #1 siRNA, Cat#4390844) and control siRNA#2
(Silencer Negative Control #1 siRNA, Cat#AM4635)
were purchased from Applied Biosystems (Foster City,
CA, USA). HeLa MR cells were transfected with
siRNAs by electroporation using a Microporator-Mini
(Digital Bio Technology, Seoul, Korea), according to the
manufacturer’s instructions. In brief, 10
5 cells were sus-
pended in 10ml of R buﬀer (provided in the
MicroPoration kit) and mixed with 1ml of one of the
siRNAs (50mM) before electroporation. The transfected
cells were suspended in fresh culture medium. After incu-
bation for 24h, the cells were reseeded in new culture
dishes at a density of 1.515   10
3/cm
2. After an additional
incubation, the cells were subjected to further assays.
Immunoﬂuorescence microscopy for NUDT16 and
single-stranded DNA
To perform immunoﬂuorescence microscopy for
NUDT16 and single-stranded DNA (ssDNA), HeLa
MR cells were seeded onto LaB-Tek two-well chamber
slides (Thermo Fisher Scientiﬁc, Rockford, IL, USA),
24h after transfection with control siRNA#1 or
NUDT16 siRNA#1. The cells were further cultured for
48h and ﬁxed with 4% paraformamide in phosphate
buﬀered saline (PBS) containing 0.1% Triton X-100.
The ﬁxed cells were treated with anti-NUDT16 or with
anti-nucleolin (sc-8031, Santa Cruz Biotechnology, Santa
Cruz, CA, USA) in combination with Alexa Fluor
488-conjugated goat anti-rabbit IgG (A-11034,
Invitrogen, Carlsbad, CA, USA) or Alexa Fluor
594-conjugated goat anti-mouse IgG (A-11032,
Invitrogen). Nuclei were counterstained with
40-diamino-2-phenylindole (DAPI) (50ng/ml; Vector
Laboratories, Burlingame, CA, USA). Digitized images
were separately captured from identical ﬁelds using an
LSM-510 Meta confocal microscopy system (Carl Zeiss,
Oberkochen, Germany).
To detect ssDNA, slides were incubated with a 100 
dilution of anti-ssDNA (#18731, IBL, Takasaki, Japan) in
combination with Alexa Fluor 488-conjugated goat
anti-rabbit IgG. The anti-ssDNA antibody was raised
against fragmented and denatured bovine DNA, and rec-
ognizes single stranded regions of DNA with a length of at
least six deoxynucleotides length (24,25). Nuclei were
counterstained with DAPI. The slide was observed
under an Axioskop 2 plus, equipped with AxioCam and
AxioVision software (Carl Zeiss). A total of 100 cells were
examined for each preparation.
Quantiﬁcation of deoxyinosine or inosine by LC-MS/MS
The DNA deoxyinosine or RNA inosine levels were
determined as follows. The preparation and digestion of
nuclear DNA samples were performed according to
methods described previously (26), except that 10mM 2,
2, 6, 6-tetramethylpiperidine-N-oxyl (TEMPO, Wako)
and 20mM2 0-deoxycoformycin, an adenosine deaminase
inhibitor, kindly provided by the Chemo-Sero-
Therapeutic Research Institute (Kumamoto, Japan),
were added to all reagents at all stages of manipulation,
according to the method described by Taghizadeh et al.
(27). RNA was prepared using an RNeasy Mini Kit
(Qiagen, Valencia, CA, USA) in the presence of 20mM
TEMPO and 20mM2 0-deoxycoformycin. DNA or RNA
samples were digested with Nuclease P1 (Yamasa, Chiba,
Japan) and alkaline phosphatase (Sigma-Aldrich) in the
presence of 20mM TEMPO and 20mM
20-deoxycoformycin, and digested samples were subjected
to LC-MS/MS analysis using the Shimadzu VP-10 HPLC
system connected to the API3000 MS/MS system
(PE-SCIEX), as described previously (26).
Cell cycle analysis
Flow cytometric analysis of the cell cycle was performed
as previously described (28,29). Brieﬂy, 1 10
6 cells were
suspended in 1ml PBS containing 0.2% Triton X for the
naked nuclei preparation. Then, the cell suspension was
passed through a nylon mesh membrane. Five microliters
of RNase A (1mg/ml) and 50ml of propidium iodide (PI)
(1mg/ml) were then added to the suspension. DNA
content and cell numbers were analyzed with an LSR
ﬂow cytometer (Becton Dickinson, San Jose, CA, USA).
The data were analyzed with CellQuest and ModFit
software (Becton Dickinson).
Karyotype analysis
Fifty-percent conﬂuent cultures of HeLa MR cells were
treated with 0.1mg/ml colcemid (Nacalai Tesque) for
30min and then harvested. After hypotonic treatment
(75mM KCl), cells were ﬁxed in freshly prepared
Carnoy’s ﬁxative (methanol:acetic acid; 3:1), and the cell
suspension was dropped onto a glass slide, air-dried and
immediately stained with freshly prepared Giemsa staining
solution (Merck, 25 diluted in PBS) for 20min. After
rinsing the slide twice in PBS and twice in distilled
water, a cover slide was mounted onto the air-dried slide
with Permount mounting medium (Thermo Fisher
Scientiﬁc). The slide was observed under an Axio
ImagerA.1 plus equipped with AxioCam and AxioVision
software (Carl Zeiss). A total of 30 cells in metaphase were
examined for each preparation.
Statistical analysis
All results are expressed as the mean±SD. Statistical
analysis was performed using Stat View 5.0 (SAS
Institute, Cary, NC, USA) and each method of statistical
analysis is shown in detail in the ﬁgure legends. P<0.05
was considered statistically signiﬁcant.
Supplementary materials and methods
Descriptions of the following materials and procedures are
provided in Supplemental Experimental Procedures: free
nucleotides, synthetic oligonucleotides, isolation of human
NUDT16 and mouse Nudt16 cDNAs, construction of
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binant His-NUDT16 protein, anti-NUDT16, western blot
analysis, cell culture, cell proliferation assay, Hoechst
33342/PI assay, real-time quantitative RT-PCR, and
comet assay.
RESULTS
NUDT16 selectively binds to ITP, XTP and GTP
To search for ITP-binding proteins, we puriﬁed proteins
from whole-cell extracts prepared from SH-SY5Y cells
using a pull-down method incorporating various
NTP-immobilized Sepharose beads (Figure 1A). The
puriﬁed proteins were fractionated by SDS-PAGE and
visualized by silver staining. The proteins in the gel were
digested with trypsin and subjected to LC-MS/MS
analysis (see ‘Materials and Methods’ section). By
comparing retrieved proteins with multiple peptide se-
quences among all samples, we identiﬁed peptide frag-
ments derived from NUDT16 only in the samples bound
to phosphate/ribose-ITP, phosphate/ribose-XTP and
ribose-GTP Sepharose beads, but not in samples bound
to any other NTP Sepharose beads (Figure 1B and
Supplementary Table S1). Western blot analysis of
pull-down samples, prepared independently of the above
samples using anti-NUDT16, conﬁrmed the LC-MS/MS
results by identifying the same nucleotide-binding 20kDa
NUDT16 protein (Figure 1C).
NUDT16 is a (deoxy)inosine diphosphatase
Because NUDT16 is a member of the nudix family of
proteins, including the nucleoside triphosphatase MTH1
(NUDT1), we performed biochemical analysis of nucleo-
tide hydrolyzing activity using recombinant NUDT16
protein. His-NUDT16 was expressed in Escherichia coli
(E. coli) and then puriﬁed. Samples from each puriﬁcation
step were subjected to SDS-PAGE and a His-NUDT16
polypeptide of  23kDa, (its calculated molecular weight
is 23.45kDa) was puriﬁed to near homogeneity after size
exclusion column chromatography (Figure 2A).
When several canonical nucleotides were incubated with
the puriﬁed His-NUDT16 protein, we found that
His-NUDT16 eﬀectively hydrolyzed IDP to IMP
(Figure 2B, lower). We then determined the optimal con-
ditions for the IDP hydrolysis by His-NUDT16.
His-NUDT16 exhibited a temperature-dependent
increase in its IDP hydrolyzing activity up to 60 C
(Supplementary Figure S1A). IDP hydrolysis by
His-NUDT16 gradually increased from pH 6.5 to 8.5
(Supplementary Figure S1B). IDP hydrolysis by
His-NUDT16 was completely dependent on the presence
of divalent cation, and increased linearly with increasing
Mg
2+ concentration up to 1mM and then reached a
plateau level (Supplementary Figure S1C). Zn
2+ also
increased His-NUDT16 activity in a dose-dependent
manner, however, the activity observed in the presence
of 10mM Zn
2+ was less than one-third of that observed
in the presence of 1mM Mg
2+. His-NUDT16 exhibited no
IDP hydrolysis in the presence of 5mM Mn
2+,C o
2+ or
Ca
2+. KCl, and to a lesser extent NaCl, moderately
increased the activity in a dose-dependent manner up to
500mM (Supplementary Figure S1D). Based on these
results and in view of physiological conditions, we per-
formed subsequent analyses of His-NUDT16 activity
under the conditions of 25mM Tris–HCl (pH 7.5),
5mMMg
2+ and 150mM KCl at 37 C.
To obtain an over view of substrate speciﬁcity for
NUDT16, we incubated His-NUDT16 with various nu-
cleotides at 10 or 100mM (Figure 2C). The products
were then analyzed and quantiﬁed by HPLC.
His-NUDT16 hydrolyzed nucleoside triphosphates/
diphosphates (NTPs/NDPs) to the corresponding nucleo-
side monophosphates (NMPs), and had substrate prefer-
ences for purine nucleotides. Especially at substrate
concentrations of 10mM, ITP, dITP, XDP, GDP,
dGDP, IDP and dIDP were eﬃciently hydrolyzed. In
contrast, His-NUDT16 did not generate any hydrolyzed
product from 7-Me-GDP, ATP, CTP, UTP, 2-OH-ATP,
dATP, dCTP, dUTP, TTP nor 2-OH-dATP, even at
100mM. Because these substrates were not hydrolyzed,
they are not represented in Figure 2C.
His-NUDT16 produced IMP from both ITP and IDP
(Supplementary Figure S2 upper). To conﬁrm the
Figure 1. NUDT16 selectively binds to XTP, ITP and GTP. (A)
Experimental scheme depicting the screen for nucleotide-binding
proteins. Proteins in extracts prepared from SH-SY5Y cells were
pulled down with NTP-immobilized Sepharose beads and subjected
to SDS-PAGE, LC-MS/MS analysis and western blot analysis. (B)
Amino acid sequence of NUDT16. Peptides detected by LC-MS/MS
analysis in the screen are shown in bold (Mascot Ion Score >45). (C)
Each sample, pulled down from the extract (219mg total protein), was
subjected to western blot analysis using anti-NUDT16 (lower panel).
An arrowhead indicates signals for NUDT16.
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analyzed the products using the Malachite Green phos-
phate detection method to distinguish Pi from pyrophos-
phates (PPi). Hydrolysis of IDP by His-NUDT16
generated almost the same amounts of IMP and Pi;
however, hydrolysis of ITP by His-NUDT16 generated
IMP but not Pi (Supplementary Figure S2 lower). These
results indicate that NUDT16 hydrolyzes IDP to IMP and
Pi, while ITP is hydrolyzed to IMP and possibly PPi.
Because His-NUDT16 eﬃciently hydrolyzed ITP, dITP,
XDP, GDP, dGDP, IDP and dIDP, we performed a
detailed analysis of the hydrolysis kinetics for these
substrates (Table 1). Fitting Michaelis–Menten type
kinetics to the initial rates of reaction revealed a positive
correlation for each substrate. Among the substrates, the
kcat/Km values for IDP and dIDP were 251 10
3 and
183 10
3s
 1M
 1, respectively. These were at least seven
times higher than the kcat/Km value for GDP
(26.2 10
3s
 1M
 1), which was the third highest among
the substrates analyzed. IDP and dIDP were, therefore,
identiﬁed as the best substrates for His-NUDT16.
We also expressed mouse His-tagged NUDT16 protein
(His-mNUDT16) in E. coli and analyzed dITP
hydrolyzing activity using extracts prepared from E. coli
cells with or without expression of His-mNUDT16. E. coli
extract without His-mNUDT16 generated dIDP and
dIMP from dITP. In contrast, E. coli extract with
His-mNUDT16 generated only dIMP from dITP
(Supplementary Figure S3). Thus, we concluded that
mouse NUDT16 also hydrolyzes dIDP to dIMP.
Expression of NUDT16 in human cell lines and tissues
We determined the levels of NUDT16 mRNA in 21 human
tissues by real-time quantitative RT-PCR (Supplementary
Figure S4). NUDT16 mRNA was detected in all tissues
examined and the highest expression was observed in lung
and kidney. Next, we examined levels of NUDT16 mRNA
and protein in HeLa MR cells with or without (si)RNA
silencing. Real-time quantitative RT-PCR revealed that
NUDT16 mRNA levels in HeLa MR cells were equivalent
to those in heart and mammary gland. The introduction of
NUDT16 siRNA#1 signiﬁcantly reduced the mRNA level
to 17% of the control after 3 days (Figure 3A). Western
blot analysis with anti-NUDT16 revealed a signiﬁcantly
reduced expression of a 20kDa protein in HeLa MR cells,
2 and 4 days after the introduction of NUDT16 siRNA#1
(Figure 3B). Other bands were consistently and uniformly
detected in samples from cells treated with control
siRNA#1 and NUDT16 siRNA#1. The expression of the
20kDa band partially recovered 7 days after the treat-
ment, thus demonstrating that the 20kDa protein is the
endogenous NUDT16 protein of HeLa MR cells.
Next, we examined subcellular localization of NUDT16
protein in HeLa MR cells by immunoﬂuorescence
confocal laser scanning microscopy with anti-NUDT16
and anti-nucleolin, a nucleolar marker (Figure 3C).
NUDT16 immunoreactivity was mostly detected in the
DAPI-positive nuclei and partially detected in the cyto-
plasm (Figure 3C-a,b,d). The signal for NUDT16 was
not uniformly localized in nuclei, but was intensely
localized in a few small regions. The intense NUDT16
signals were mostly colocalized with the intense nucleolin
signals where DAPI signals were faint (Figure 3C-d–f).
Figure 2. His-NUDT16 hydrolyzes (d)IDP in preference to other nu-
cleotides. (A) Samples from the puriﬁcation of recombinant
His-NUDT16 were subjected to SDS-PAGE and GelCode Blue
Staining. Lane 1, supernatant of E. coli extract; lane 2, ﬂow-through
fraction from the His-tag puriﬁcation; lane 3, eluate from His-tag
puriﬁcation; lane 4, fraction recovered by ammonium sulfate precipita-
tion; lane 5, sample after dialysis; lane 6, eluate from cation exchange
chromatography; lane 7, fraction recovered from gel ﬁltration chroma-
tography. (B) IDP (200mM) was incubated with 400nM His-NUDT16
for 1h at 37 C. Reaction products were analyzed by HPLC
(lower panel), and were compared with substrate IDP incubated
without His-NUDT16 (upper panel). HPLC chromatograms of both
samples obtained by absorbance at 249nm are shown. (C) Nucleoside
di- or triphosphates (10 or 100mM) were incubated with 50nM
His-NUDT16 for 1h at 37 C. The reaction products were analyzed
by HPLC. The graph shows the concentration of each nucleoside
monophosphate product.
Table 1. Kinetic parameters of His-NUDT16
Km kcat kcat/Km Goodness-of-curve ﬁt
Substrate mM min
 1 10
3s
 1M
 1 R
2
IDP 0.062 0.931 251 0.973
dIDP 0.088 0.966 183 0.990
GDP 0.330 0.518 26.1 0.987
dGDP 0.319 0.492 25.7 0.988
XDP 15.7 2.60 2.76 0.978
ITP 22.1 3.06 2.31 0.980
dITP 24.1 3.20 2.21 0.999
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cells treated with NUDT16 siRNA#1 (Figure 3C-h). We
thus concluded that NUDT16 protein is mostly localized
in nucleoli.
Knockdown of NUDT16 expression suppresses
proliferation of HeLa MR cells
To elucidate the biological functions of NUDT16, we
examined the eﬀects of NUDT16 knockdown in HeLa
MR cells. Twenty-four hours after the introduction of
siRNA, the cells were reseeded. We then compared cell
proliferation rates between cells treated with control
siRNA#1 and those treated with NUDT16 siRNA#1
(Figure 4A). NUDT16 siRNA#1 signiﬁcantly suppressed
cell proliferation compared with the control siRNA
(Figure 4B). Introduction of NUDT16 siRNA#2,
which has a diﬀerent target sequence for NUDT16, also
similarly suppressed the proliferation of HeLa MR cells,
conﬁrming the eﬀect of NUDT16 knockdown
(Supplementary Figure S5A and B). Next, we performed
a ﬂow cytometric analysis of DNA content of HeLa MR
cells after NUDT16 knockdown. Cell cycle analysis
revealed signiﬁcantly increased S-phase and decreased
G1 phase populations after introduction of NUDT16
siRNA#1 (Figure 4C). Moreover, Hoechst 33342/PI
Figure 3. NUDT16 is mainly localized in nuclei, and especially in
nucleoli. (A) Relative mRNA level after transfection of NUDT16
siRNA. Three days after transfection with siRNAs, cells were har-
vested. The NUDT16 mRNA level relative to that of the control
was determined by real time quantitative RT-PCR and is shown as
the mean ± SD of triplicate experiments. (B) Cells were transfected
with siRNAs and harvested 2, 4, and 7 days after transfection. Cell
extracts (10mg total protein) were subjected to western blot analysis
with anti-NUDT16. An arrowhead indicates signals for NUDT16.
(C) Intracellular localization of NUDT16. HeLa MR cells were trans-
fected with control siRNA#1 (a–f) or with NUDT16 siRNA#1 (g–i).
The cells were subjected to immunoﬂuorescence microscopy with
anti-NUDT16 (green, b and h) and anti-nucleolin (red, c and i).
Nuclei were stained with DAPI (blue, a and g). Merged signals are
shown in panel d (blue and green), e (green and red) and f (blue,
green and red). Bars indicate 10mm.
Figure 4. Knockdown of NUDT16 suppresses proliferation of HeLa
MR cells. (A) Experimental schedule. HeLa MR cells were transfected
with siRNAs on Day 0. The transfected cells were then further
incubated for 24h before replating at a density of 1.5 10
3/cm
2.
After an additional incubation, the cells were subjected to further
analysis. (B) Cell proliferation assay. The cells in (A) were analyzed
for cell proliferation. The graph shows the mean±SD of results from
three independent siRNA transfections. Two-way repeated measures
ANOVA, P<0.0001. (C) HeLa MR cells treated with NUDT16
siRNA#1 show slightly abnormal progression of the cell cycle. Three
days after siRNA transfection with NUDT16 siRNA#1 or with control
siRNA#1, cells were subjected to ﬂow cytometry. Left panels indicate
representative histograms of DNA contents in isolated nuclei from
these cells. Data are mean±SD of results from three independent
siRNA transfections and were analyzed using Student’s t-test.
Nucleic Acids Research, 2010,Vol.38, No. 14 4839staining of the cells revealed that introduction of
NUDT16 siRNA#1 caused no obvious increase in the
dead cell fraction (PI positive) in comparison to control
siRNA#1 (Supplementary Figure S6). We observed no
subG1 fraction, indicating that NUDT16 knockdown did
not induce cell death in our experimental conditions
(Figure 4C).
Accumulation of inosine nucleotides in RNA and of single
strand breaks in DNA after knockdown of NUDT16
expression
The localization of NUDT16 in nuclei strongly suggested
that NUDT16 contributes to sanitization of the nuclear
nucleotide pool, which supplies precursors for the synthe-
sis of RNA and DNA. We, therefore, measured inosine in
cellular RNA and deoxyinosine in nuclear DNA in
HeLa MR cells after NUDT16 knockdown by siRNA.
The inosine level in RNA was signiﬁcantly increased in
cells treated with NUDT16 siRNA#1 (36.1±1.35
inosine residues per 10
6 guanosine residues) compared
with cells treated with control siRNA#1 (31.9±1.05
inosine residues per 10
6 guanosine residues) (P=0.0125)
(Figure 5A right). However, there was no signiﬁcant dif-
ference in the deoxyinosine level in DNA between the two
conditions (Figure 5A left). These results suggested that
ITP or dITP levels are increased after NUDT16
knockdown, and that their incorporation into RNA or
DNA may be similarly increased; however, deoxyinosine
incorporated into newly synthesized DNA might be
quickly eliminated by DNA repair enzymes. DNA repair
processes often form ssDNA regions as repair inter-
mediates (30–32). Therefore, we examined ssDNA accu-
mulation in nuclear DNA of HeLa MR cells by
immunoﬂuorescence detection using an anti-ssDNA
antibody after siRNA treatment. The anti-ssDNA
antibody was raised against fragmented bovine DNA,
and recognizes ssDNA generated by double- or
single-strand DNA breaks (33). Following treatment
with NUDT16 siRNA, the percentage of ssDNA-positive
HeLa MR cells (13.9%) was 5.3 times higher than that
treated with control siRNA (P=0.000252) (Figure 5B).
ssDNA regions can be generated by either single- or
double-strand breaks in DNA. In the comet assay, HeLa
Figure 5. Knockdown of NUDT16 in HeLa MR cells increases the number of inosine residues in RNA and the level of single strand breaks in
nuclear DNA. HeLa MR cells were independently transfected with siRNAs three times. Three days after transfection, cells were subjected to the
following analysis. (A) Quantiﬁcation of inosine or deoxyinosine by LC-MS/MS. HeLa MR cells were harvested to determine the levels of inosine
and deoxyinosine [dI]. The numbers of deoxyinosine residues [dI] per 10
6 nucleosides in DNA or inosine residues per 10
6 guanosine [G] in RNA from
three independent transfections are shown. Student’s t-test, P=0.0125 (RNA). (B) Knockdown of NUDT16 induces the accumulation of ssDNA in
nuclei of HeLa MR cells. HeLa MR cells transfected with control siRNA#1 (a–c) or with NUDT16 siRNA#1 (d–f) were subjected to immuno-
ﬂuorescence microscopy with anti-ssDNA (green, b and e). Nuclei were stained with DAPI (blue, a and d). Merged signals are shown in c and f (blue
and green). Percentages of ssDNA-positive nuclei among DAPI-positive nuclei are shown in the bar graph. Data are mean±SD of three inde-
pendent siRNA transfections. Student’s t-test, P=0.000252. (C) Comet assay under alkaline conditions. Tail moments of at least 15 cells were
calculated for each group and box-and-whisker plots are shown for three independent assays. Mann–Whitney U-test, P<0.05. (D) Chromosomal
abnormality. Transfected cells were prepared as in (B). Mitotic cells with chromosomal abnormalities (a) were deﬁned as cells with chromatid
breakage (b; solid arrowheads), chromatid gap (c; open arrowheads) and/or premature separation (d; arrows). These cells were counted and per-
centages of cells with chromosomal abnormalities among thirty mitotic cells are shown in the bar graph. Chromatid breakage, chromatid gap, and
premature separation in control cells were 8%, 2% and 0%, respectively, and in NUDT16 knockdown cells were12%, 4% and 1%, respectively. Data
are mean±SD from three independent siRNA transfections.
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niﬁcantly increased tail moment under alkaline conditions
in three independent experiments (P<0.05, Mann–
Whitney U-test), but not under neutral conditions
(Figure 5C and Supplementary Figure S7). Cells exposed
to hydrogen peroxide, which is known to cause
double-strand breaks, exhibited a signiﬁcantly increased
tail moment, even under neutral conditions; therefore we
concluded that knockdown of NUDT16 caused accumu-
lation of single-strand breaks in nuclear DNA. Next,
chromosome abnormalities including chromatid
breakage, chromatid gap, and/or premature separation
were examined in mitotic cells. The percentage of the
cells with abnormal chromosomes in HeLa MR cells
treated with NUDT16 siRNA was 1.8 times higher than
that in cells treated with control siRNA, although the dif-
ference was not signiﬁcant (P=0.115) (Figure 5D).
DISCUSSION
In the present study, we reported two major ﬁndings; ﬁrst,
NUDT16 hydrolyzes (d)IDP/(d)ITP and second,
NUDT16 deﬁciency induces accumulation of single
strand breaks in nuclear DNA and growth arrest in
human cells.
Previously, Ghosh et al. (34) reported that NUDT16
recognizes the 50-cap structure of U8 small nucleolar
RNA (snoRNA) and weakly hydrolyzes it to produce
non-capped-snoRNA with guanosine 50-monophosphate
at its 50-terminus and an excised cap. First guanosine
residue of U8 snoRNA itself is linked to the triphosphate
following the 50-cap, and thus mimicking a GTP structure.
GTP was shown to be weakly hydrolyzed by NUDT16 in
the present study. Therefore, both 50-capped U8 snoRNA
and GTP can be converted by NUDT16 to guanosine
50-monophosphate (GMP) at the 50-terminal end of
snoRNA and to free GMP, respectively. Thus, it is
likely that hydrolysis of GTP and decapping of U8
snoRNA are essentially the same enzyme reaction of
NUDT16. We also showed that in a human cell line,
NUDT16 is localized in nuclei, mainly nucleoli.
Similarly, Ghosh et al. (34) have reported that X29
protein, the Xenopus homolog of NUDT16, is primarily
a nucleolar protein in Xenopus cells in vitro.
As shown in Figure 6, NUDT16 eﬃciently hydrolyzes
(d)IDP, and hydrolyzes (d)ITP to a lesser extent. (d)ITP
and (d)IDP can be generated by deamination of adenine
nucleotides or phosphorylation of (d)IMP (35). ITPA,
which is relatively abundant in the cytoplasm and which
is encoded by ITPA, is known to hydrolyze (d)ITP to
(d)IMP and pyrophosphate (14,15). The study of
NUDT16 reaction kinetics revealed that NUDT16 has a
lower hydrolysis rate but a higher aﬃnity for (d)ITP
compared with ITPA (for ITP; NUDT16, kcat 3.2min
 1,
Km 22.1mM; ITPA, kcat 34800min
 1, Km 510mM) (15).
NUDT16, therefore, might be an important enzyme for
the elimination of (deoxy)inosine nucleotides from nuclei,
especially at low concentrations. Because NUDT16 is
localized mainly in nucleoli, NUDT16 may prevent the
incorporation of inosine nucleotides into ribosomal
RNA (rRNA) during transcription. An increase in the
RNA inosine level, observed after the knockdown of
NUDT16 supports this hypothesis. NUDT16, but not
ITPA, has a strong hydrolysis activity for (d)IDP. In the
pathway converting abundant cellular IMP to ITP by
phosphorylation (10), IDP is an important intermediate.
In addition, IDP is expected to be converted to dIDP by
ribonucleotide reductase (36), and dIDP can be
phosphorylated, thereby resulting in increased levels of
dITP (11).
8-oxo-dGTP is known to be incorporated into genomic
DNA and to induce mutation in both mammalian and
bacterial cells (3). Human NUDT5, which hydrolyzes
8-oxo-dGDP, was reported to decrease spontaneous
mutation in E. coli mutT
  cells deﬁcient in 8-oxo-dGTP
hydrolyzing activity (37). Taken together with our ﬁndings
on NUDT16, these results support the importance of the
elimination of modiﬁed (deoxy)nucleoside diphosphates
from the nucleotide pools.
In the present study, we observed the deoxyinosine
levels in nuclear DNA within the normal ranges previous-
ly observed by Taghizadeh et al. (27) even after
knockdown of NUDT16. However, knockdown of
NUDT16 expression increased the fraction of
ssDNA-positive cells. We assume that the dITP level in
the nuclear nucleotide pool must increase after NUDT16
knockdown, thus resulting in increased incorporation of
deoxyinosine into newly synthesized DNA. The
deoxyinosine in DNA is immediately removed by the
DNA repair process, resulting in an accumulation of
ssDNA. Bradshaw and Kuzminov (38) described the in-
corporation of dITP/dXTP into the genomic DNA of
rdgB
  E. coli cells, which lack bacterial ITPase. In
E. coli cells, DNA containing deoxyinosine can be
excised by Endo V-initiated nucleotide excision repair,
thus resulting in DNA strand breakage (32). Both Endo
V and another enzyme, alkyl-adenine-DNA glycosylase
(AAG, MAG, ANPG, MPG) were reported as candidates
for hypoxanthine speciﬁc DNA repair enzymes in
Figure 6. Model of biological roles of NUDT16. NUDT16 eliminates
(d)IDP and (d)ITP from the nucleotide pools in cooperation with
ITPA. NDK; nucleoside diphosphate kinases, RNR; ribonucleotide
reductase.
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accumulation of ssDNA triggers the DNA damage
response, to induce delay in S-phase, and then cell cycle
arrest (42). We, therefore, assume that the DNA damage
response, to the accumulation of ssDNA, suppresses cell
cycle progression, thus increasing the S-phase population
and resulting in a decreased proliferation rate. On the
other hand, knockdown of NUDT16 expression induced
a 13.3% increase in RNA inosine levels. RNA editing by
adenosine deaminases is a well-known system of
post-transcriptional regulation and the major source of
inosine in RNA; therefore, more inosine residues are
present in RNA compared with deoxyinosine residues in
DNA (43,44). Inosine, produced in RNA by such a
regulated system, is thought to cause important modiﬁca-
tions to the functions of non-coding RNA, or to alter
amino acid sequence encoded by mRNA (45,46). In
other words, unregulated incorporation of inosine
during RNA transcription might impair RNA functions.
In the present study, we demonstrated that NUDT16 con-
tributes to the suppression of such inosine incorporation
into RNA. Although the increased level of inosine in
RNA under NUDT16 deﬁciency was statistically signiﬁ-
cant and the net increase was much higher than the basal
level of deoxyinosine in DNA (4.3 inosine/10
6G versus
0.63 deoxyinosine/10
6dG), the higher basal level of
inosine in RNA (32 inosine/10
6G), which is likely to be
generated by RNA-editing (45,46), made the diﬀerence
appear small.
We previously reported that Itpa
 /  mice showed
growth retardation and heart failure and did not survive
beyond 2 weeks after birth (16). Following this report, we
found that primary mouse embryonic ﬁbroblasts (MEFs)
prepared from Itpa
 /  mice showed a signiﬁcantly pro-
longed doubling time and chromosomal abnormalities,
accompanied by increased ssDNA and deoxyinosine
residues in nuclear DNA (47). However, once Itpa
 / 
MEFs were spontaneously immortalized, the
immortalized Itpa
 /  MEFs had neither of these pheno-
types. Furthermore, immortalized Itpa
 /  MEFs ex-
hibited signiﬁcantly increased levels of Nudt16 mRNA
and protein. siRNA-mediated knockdown of Nudt16 in
immortalized Itpa
 /  MEFs signiﬁcantly increased
deoxyinosine levels in nuclear DNA, and thus reproduced
the ITPA-deﬁcient phenotype. We, therefore, concluded
that mouse NUDT16 functions as a backup enzyme for
the ITPA deﬁciency by eliminating (d)IDP, and to a lesser
extent (d)ITP from the nucleotide pools in MEFs. In
wild-type MEFs, knockdown of Nudt16 did not result in
such phenotypes, indicating that mouse ITPA can com-
pensate for the deﬁciency of NUDT16 in MEFs. In
contrast, our present data suggested that human ITPA
itself cannot completely compensate for the deﬁciency of
NUDT16 in HeLa MR cells, although double deﬁciency
of ITPA and NUDT16 would cause more severe pheno-
types. Human individuals with ITPA deﬁciency show no
obvious phenotypes. Thus, ITPA deﬁciency causes quite
diﬀerent eﬀects in mouse and human. Comparing the ex-
pression level or enzyme activity of NUDT16 between
mouse and human might explain why human cells have
a signiﬁcant tolerance to ITPA deﬁciency. In the present
study, partial reduction of NUDT16 expression in HeLa
MR cells was suﬃcient to cause growth suppression and
accumulation of single-strand breaks in nuclear DNA.
Therefore, defective NUDT16 might lead to genome-
instability syndromes in human individuals.
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